Titan Pharmaceuticals
$0.37039876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.3703
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0415 (-10.31%) Today
+$0.0094 (2.60%) As of 6:47 PM EDT after-hours
Why Robinhood?
You can buy or sell TTNP and other stocks, options, ETFs, and crypto commission-free!
About TTNP
Titan Pharmaceuticals, Inc. Common Stock, also called Titan Pharmaceuticals, is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Read More Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.
Employees
23
Headquarters
South San Francisco, California
Founded
1992
Market Cap
5.68M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
515.65K
High Today
$0.40
Low Today
$0.35
Open Price
$0.40
Volume
469.74K
52 Week High
$3.78
52 Week Low
$0.35
Collections
Price Paid on Robinhood
57% Lower
Right Now
Average Price Paid
$0.8661
52 Week Low
$1.03
52 Week High
$6.90
TTNP Earnings
-$0.38
-$0.27
-$0.15
-$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 14, After Hours